Bill Sponsor
House Bill 3080
116th Congress(2019-2020)
Comprehensive TB Elimination Act of 2019
Introduced
Introduced
Introduced in House on Jun 4, 2019
Overview
Text
Introduced
Jun 4, 2019
Latest Action
Jun 5, 2019
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
3080
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Sponsorship by Party
Democrat
New York
Republican
Alaska
Democrat
California
Democrat
California
Democrat
California
Democrat
California
Democrat
California
Democrat
Florida
Democrat
Maryland
Democrat
Massachusetts
Democrat
Massachusetts
Republican
New Jersey
Republican
Pennsylvania
House Votes (0)
Senate Votes (0)
No House votes have been held for this bill.
Summary

Comprehensive TB Elimination Act of 2019

This bill reauthorizes for FY2020-FY2025 and revises the tuberculosis (TB) prevention and treatment grant program administered by the Centers for Disease Control and Prevention. The Health Resources and Services Administration may also award grants to state and local governments and federally qualified health centers for TB prevention and treatment efforts.

Additionally, the Government Accountability Office must report on national TB prevention and treatment efforts.

Text (1)
Actions (3)
06/05/2019
Referred to the Subcommittee on Health.
06/04/2019
Referred to the House Committee on Energy and Commerce.
06/04/2019
Introduced in House
Public Record
Record Updated
Nov 1, 2022 6:32:26 AM